| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |